These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11509914)

  • 21. Quantification of the inhomogeneous distribution of topically applied substances by optical spectroscopy: definition of a factor of inhomogeneity.
    Weigmann HJ; Schanzer S; Vergou T; Antoniou C; Sterry W; Lademann J
    Skin Pharmacol Physiol; 2012; 25(3):118-23. PubMed ID: 22343548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources.
    Pershing LK; Bakhtian S; Poncelet CE; Corlett JL; Shah VP
    J Pharm Sci; 2002 May; 91(5):1312-23. PubMed ID: 11977107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
    Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
    Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects.
    Au WL; Skinner MF; Benfeldt E; Verbeeck RK; Kanfer I
    Skin Pharmacol Physiol; 2012; 25(1):17-24. PubMed ID: 21860254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream.
    Teichmann A; Heuschkel S; Jacobi U; Presse G; Neubert RH; Sterry W; Lademann J
    Eur J Pharm Biopharm; 2007 Nov; 67(3):699-706. PubMed ID: 17537622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo assessment of the cutaneous bioavailability of topically applied maxacalcitol.
    Ikeda Y; Hirata K; Kano S; Yanagihara H; Takahara J; Kondo K; Umemura K
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):305-10. PubMed ID: 16082417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the vehicle on the amount of stratum corneum removed by tape stripping.
    Jacobi U; Meykadeh N; Sterry W; Lademann J
    J Dtsch Dermatol Ges; 2003 Nov; 1(11):884-9. PubMed ID: 16281579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement, analysis and prediction of topical UV filter bioavailability.
    Roussel L; Gilbert E; Salmon D; Serre C; Gabard B; Haftek M; Maibach HI; Pirot F
    Int J Pharm; 2015 Jan; 478(2):804-10. PubMed ID: 25526673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption.
    Weigmann H; Lademann J; Meffert H; Schaefer H; Sterry W
    Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):34-45. PubMed ID: 10325582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical comparison of methods to quantify stratum corneum removed by tape stripping.
    Marttin E; Neelissen-Subnel MT; De Haan FH; Boddé HE
    Skin Pharmacol; 1996; 9(1):69-77. PubMed ID: 8868035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical ultraviolet absorbers topically applied in a skin barrier mimetic formulation remain in the outer stratum corneum of porcine skin.
    Haque T; Crowther JM; Lane ME; Moore DJ
    Int J Pharm; 2016 Aug; 510(1):250-4. PubMed ID: 27321112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.
    Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A
    Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of nonhomogeneous distribution of topically applied UV filters on sun protection factors.
    Lademann J; Rudolph A; Jacobi U; Weigmann HJ; Schaefer H; Sterry W; Meinke M
    J Biomed Opt; 2004; 9(6):1358-62. PubMed ID: 15568958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of in vivo bioequivalence methodology for topical clobetasol 17-propionate based on pharmacodynamic modeling using Chinese skin.
    Tsai JC; Cheng CL; Tsai YF; Sheu HM; Chou CH
    J Pharm Sci; 2004 Jan; 93(1):207-17. PubMed ID: 14648650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo.
    Ashworth J; Watson WS; Finlay AY
    Br J Dermatol; 1988 Sep; 119(3):351-8. PubMed ID: 3179208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.